Lucid Diagnostics (LUCD) Other Non-Current Liabilities (2024 - 2026)
Lucid Diagnostics posted quarterly Other Non-Current Liabilities of $25.2 million for Q1 2026, up 35.48% on a QoQ basis from $18.6 million in Q4 2024.
Lucid Diagnostics (LUCD) has 2 years of Other Non-Current Liabilities data on file, last reported at $25.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $25.2 million; the trailing twelve-month figure through Mar 2026 stood at $25.2 million (changed N/A YoY), and the FY2024 full-year result was $18.6 million, changed N/A from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $25.2 million, up from $18.6 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $25.2 million in Q1 2026 and bottomed at $18.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lucid Diagnostics | 145.00 Mn | 117.12 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.20 Mn |
| Dec 31, 2024 | 18.60 Mn |